Aeterna Zentaris Inc. (NASDAQ:AEZS) reported that the formal implementation of its own full-time U.S. sales force with field selling of ASCEND Therapeutics US LLC's, EstroGel, slated to start the week of November 17, 2014. Aeterna Zentaris Inc. (NASDAQ:AEZS) begun last trade with a price of $1.23 and throughout the trading session climbed at a high of $1.34. The day-trade ended with 4.27% to $1.22. The stock is going forward to its 52 week low with 48.78% and lagging behind from its 52 week high price with -29.89%. AEZS last month stock price volatility remained 7.24%.Tenneco Inc. (NYSE:TEN) released its third quarter earnings of $1.25 a share, excluding non-recurring items, $0.12 improved than the Capital IQ Consensus anticipates of $1.13; revenues rose 6% year/year to $2.081B as compared to the $2.1B consensus. Tenneco Inc. (NYSE:TEN) has the market capitalization of 3.071 Billion. Shares of firm moved down -7.83% to close at $50.29 with the total traded volume of 4.22 Million. The firm has current ratio of 1.40 for the most recent quarter.Zogenix, Inc. (NASDAQ:ZGNX) declared that that it purchased Brabant Pharma, a privately-held U.K.-based pharmaceutical firm for $20M in cash and $15M in stock plus possible future milestone and royalty payments. The purchase comprises worldwide development and commercialization rights to BrabafenTM, low-dose fenfluramine, for the treatment of Dravet syndrome, a rare and catastrophic form of intractable epilepsy that begins in infancy. Zogenix, Inc. (NASDAQ:ZGNX) stock price closed at $1.27 with the total traded volume of 807690 shares. Its price to sales ratio ended at 5.28. Its market capitalization is 179.1 Million. The stock owned by the Financial Institutions was 79.80% while by insiders was 2.30%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
